pI: 7.921 |
Length (AA): 841 |
MW (Da): 97338 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
250 | 715 | 2db3 (A) | 225 | 599 | 22.00 | 0 | 1 | 0.59 | 0.14 |
295 | 485 | 1q0u (A) | 24 | 211 | 22.00 | 0.000000078 | 1 | 0.65 | -1.48 |
3 | 57 | 3iuy (A) | 235 | 286 | 46.00 | 0.024 | 0.48 | 0.478798 | 0.36 |
4 | 66 | 3ber (A) | 26 | 88 | 43.00 | 0.00063 | 0.99 | 0.690311 | -0.95 |
339 | 717 | 1hv8 (A) | 70 | 348 | 31.00 | 0 | 1 | 0.439054 | 0.53 |
575 | 706 | 2hjv (A) | 226 | 341 | 37.00 | 0.0000000022 | 1 | 0.630356 | -1.42 |
609 | 729 | 1hv8 (A) | 242 | 362 | 27.00 | 0.34 | 1 | 0.559476 | -0.77 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | merozoite, sporozoite, early ring, early trophozoite, late ring, Ring. | PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, early schizont, late trophozoite, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, Oocyst, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Ortholog group members (OG5_130919)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III003880 | DEAD/DEAH box helicase domain containing protein |
Brugia malayi | Bm1_11355 | ATP-dependent helicase DDX1 |
Caenorhabditis elegans | CELE_Y55F3BR.1 | Protein Y55F3BR.1 |
Dictyostelium discoideum | DDB_G0269966 | DEAD/DEAH box helicase |
Drosophila melanogaster | Dmel_CG9054 | Dead-box-1 |
Echinococcus granulosus | EgrG_000545600 | ATP dependent RNA helicase Ddx1 |
Echinococcus multilocularis | EmuJ_000545600 | ATP dependent RNA helicase Ddx1 |
Homo sapiens | ENSG00000079785 | DEAD (Asp-Glu-Ala-Asp) box helicase 1 |
Loa Loa (eye worm) | LOAG_08173 | ATP-dependent helicase DDX1 |
Loa Loa (eye worm) | LOAG_05806 | hypothetical protein |
Mus musculus | ENSMUSG00000037149 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
Neospora caninum | NCLIV_002510 | ATP-dependent RNA helicase DDX family protein, putative |
Plasmodium berghei | PBANKA_1236300 | ATP-dependent RNA helicase DDX1, putative |
Plasmodium falciparum | PF3D7_0521700 | ATP-dependent RNA helicase DDX1, putative |
Plasmodium knowlesi | PKNH_1011200 | ATP-dependent RNA helicase DDX1, putative |
Plasmodium vivax | PVX_080160 | DEAD/DEAH box ATP-dependent RNA helicase, putative |
Plasmodium yoelii | PY01366 | ATP-dependent helicase ddx1 |
Schistosoma japonicum | Sjp_0011260 | ATP-dependent RNA helicase DDX1, putative |
Schistosoma japonicum | Sjp_0003220 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma japonicum | Sjp_0008650 | ATP-dependent RNA helicase DDX1, putative |
Schistosoma japonicum | Sjp_0217350 | ATP-dependent RNA helicase DDX1, putative |
Schistosoma mansoni | Smp_163110 | DEAD box ATP-dependent RNA helicase |
Schmidtea mediterranea | mk4.008454.02 | |
Schmidtea mediterranea | mk4.004138.02 | |
Schmidtea mediterranea | mk4.004138.01 | ATP-dependent RNA helicase DDX1 |
Schmidtea mediterranea | mk4.004138.03 | |
Toxoplasma gondii | TGME49_207430 | ATP-dependent RNA helicase DDX1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_Y55F3BR.1 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_207430 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.